Iranian Journal of Radiology

Published by: Kowsar

Comparison of Different Dynamic Contrast Enhanced-Magnetic Resonance Imaging Descriptors and Clinical Findings Among Breast Cancer Subtypes Determined Based on Molecular Assessment

Serap Dogan 1 , * , Soner Ozmen 2 , Bahadir Oz 3 , Hakan Imamoglu 1 , Guven Kahriman 1 , Gokmen Zararsiz 4 and Mustafa Ozturk 1
Authors Information
1 Department of Radiology, Erciyes University Medical Faculty, Kayseri, Turkey
2 Department of Radiology, Gumushane State Hospital, Gumushane, Turkey
3 Department of General Surgery, Erciyes University Medical Faculty, Kayseri, Turkey
4 Department of Biostatistics, Erciyes University Medical Faculty, Kayseri, Turkey
Article information
  • Iranian Journal of Radiology: October 2018, 15 (4); e64889
  • Published Online: September 22, 2018
  • Article Type: Research Article
  • Received: December 8, 2017
  • Revised: May 23, 2018
  • Accepted: July 28, 2018
  • DOI: 10.5812/iranjradiol.64889

To Cite: Dogan S, Ozmen S, Oz B, Imamoglu H, Kahriman G, et al. Comparison of Different Dynamic Contrast Enhanced-Magnetic Resonance Imaging Descriptors and Clinical Findings Among Breast Cancer Subtypes Determined Based on Molecular Assessment, Iran J Radiol. 2018 ; 15(4):e64889. doi: 10.5812/iranjradiol.64889.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York, NY: Springer; 2009. p. 347-76.
  • 2. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747-52. doi: 10.1038/35021093. [PubMed: 10963602].
  • 3. Huber KE, Carey LA, Wazer DE. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy. Semin Radiat Oncol. 2009;19(4):204-10. doi: 10.1016/j.semradonc.2009.05.004. [PubMed: 19732684].
  • 4. Mazurowski MA, Zhang J, Grimm LJ, Yoon SC, Silber JI. Radiogenomic analysis of breast cancer: Luminal B molecular subtype is associated with enhancement dynamics at MR imaging. Radiology. 2014;273(2):365-72. doi: 10.1148/radiol.14132641. [PubMed: 25028781].
  • 5. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15 Pt 1):4429-34. doi: 10.1158/1078-0432.CCR-06-3045. [PubMed: 17671126].
  • 6. Costantini M, Belli P, Distefano D, Bufi E, Matteo MD, Rinaldi P, et al. Magnetic resonance imaging features in triple-negative breast cancer: Comparison with luminal and HER2-overexpressing tumors. Clin Breast Cancer. 2012;12(5):331-9. doi: 10.1016/j.clbc.2012.07.002. [PubMed: 23040001].
  • 7. Youk JH, Son EJ, Chung J, Kim JA, Kim EK. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: Comparison with other breast cancer subtypes. Eur Radiol. 2012;22(8):1724-34. doi: 10.1007/s00330-012-2425-2. [PubMed: 22527371].
  • 8. Uematsu T, Kasami M, Yuen S. Triple-negative breast cancer: Correlation between MR imaging and pathologic findings. Radiology. 2009;250(3):638-47. doi: 10.1148/radiol.2503081054. [PubMed: 19244039].
  • 9. Dogan BE, Gonzalez-Angulo AM, Gilcrease M, Dryden MJ, Yang WT. Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR Am J Roentgenol. 2010;194(4):1160-6. doi: 10.2214/AJR.09.2355. [PubMed: 20308526].
  • 10. Grimm LJ, Johnson KS, Marcom PK, Baker JA, Soo MS. Can breast cancer molecular subtype help to select patients for preoperative MR imaging? Radiology. 2015;274(2):352-8. doi: 10.1148/radiol.14140594. [PubMed: 25325325].
  • 11. Ha R, Jin B, Mango V, Friedlander L, Miloshev V, Malak S, et al. Breast cancer molecular subtype as a predictor of the utility of preoperative MRI. AJR Am J Roentgenol. 2015;204(6):1354-60. doi: 10.2214/AJR.14.13666. [PubMed: 26001248].
  • 12. American College of Radiology . Breast imaging and reporting and data system (ACR BI-RADS®Atlas). 5th ed. Reston, VA: American College of Radiology; 2013.
  • 13. Rakha EA, El-Sayed ME, Lee AH, Elston CW, Grainge MJ, Hodi Z, et al. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol. 2008;26(19):3153-8. doi: 10.1200/JCO.2007.15.5986. [PubMed: 18490649].
  • 14. Lam SW, Jimenez CR, Boven E. Breast cancer classification by proteomic technologies: Current state of knowledge. Cancer Treat Rev. 2014;40(1):129-38. doi: 10.1016/j.ctrv.2013.06.006. [PubMed: 23891266].
  • 15. Kyndi M, Sorensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J, et al. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26(9):1419-26. doi: 10.1200/JCO.2007.14.5565. [PubMed: 18285604].
  • 16. Kato F, Kudo K, Yamashita H, Wang J, Hosoda M, Hatanaka KC, et al. Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI. Eur J Radiol. 2016;85(1):96-102. doi: 10.1016/j.ejrad.2015.10.018. [PubMed: 26724653].
  • 17. Lee SH, Cho N, Kim SJ, Cha JH, Cho KS, Ko ES, et al. Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Radiol. 2008;9(1):10-8. doi: 10.3348/kjr.2008.9.1.10. [PubMed: 18253071]. [PubMed Central: PMC2627175].
  • 18. Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res. 2007;13(8):2329-34. doi: 10.1158/1078-0432.CCR-06-1109. [PubMed: 17438091].
  • 19. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100(14):8418-23. doi: 10.1073/pnas.0932692100. [PubMed: 12829800]. [PubMed Central: PMC166244].
  • 20. Alili C, Pages E, Curros Doyon F, Perrochia H, Millet I, Taourel P. Correlation between MR imaging - prognosis factors and molecular classification of breast cancers. Diagn Interv Imaging. 2014;95(2):235-42. doi: 10.1016/j.diii.2014.01.002. [PubMed: 24525088].
  • 21. Boudin L, Chabannon C, Sfumato P, Sabatier R, Bertucci F, Tarpin C, et al. Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation. Eur J Cancer. 2016;57:118-26. doi: 10.1016/j.ejca.2016.01.005. [PubMed: 26918737].
  • 22. Jimenez RE, Wallis T, Visscher DW. Centrally necrotizing carcinomas of the breast: A distinct histologic subtype with aggressive clinical behavior. Am J Surg Pathol. 2001;25(3):331-7. doi: 10.1097/00000478-200103000-00007. [PubMed: 11224603].
  • 23. Trop I, LeBlanc SM, David J, Lalonde L, Tran-Thanh D, Labelle M, et al. Molecular classification of infiltrating breast cancer: Toward personalized therapy. Radiographics. 2014;34(5):1178-95. doi: 10.1148/rg.345130049. [PubMed: 25208275].
  • 24. Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, et al. Diagnostic architectural and dynamic features at breast MR imaging: Multicenter study. Radiology. 2006;238(1):42-53. doi: 10.1148/radiol.2381042117. [PubMed: 16373758].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments